Results 261 to 270 of about 708,976 (400)

Vascular smooth muscle cell plasticity in the tumor microenvironment. [PDF]

open access: yesCancer Commun (Lond)
Bell CF   +12 more
europepmc   +1 more source

Atrial Natriuretic Factor (ANF) Inhibits Ca-Dependent K-Fluxes in Cultured Vascular Smooth Muscle Cells

open access: bronze, 1986
Ricardo P. Garay   +9 more
openalex   +1 more source

ATF3 Deficiency Exacerbates Ageing‐Induced Atherosclerosis and Clinical Intervention Strategy

open access: yesAdvanced Science, EarlyView.
Targeting ATF3 with terazosin to against VSMC Senescence and atherosclerosis. TZ reduces the binding affinity of YTHDF2 to Atf3 mRNA, while enhancing mRNA stability. ATF3 promotes Atg7 transcription, enhancing autophagy. ATG7 binds to ATF3 in the cytoplasm, facilitating ATF3 translocation to the nucleus and establishing positive feedback. By modulating
Hao Nie   +11 more
wiley   +1 more source

Brain natriuretic peptide interacts with atrial natriuretic peptide receptor in cultured rat vascular smooth muscle cells [PDF]

open access: bronze, 1988
Yukio Hirata   +5 more
openalex   +1 more source

Vascular Smooth Muscle Cell Phenotypic Changes in Patients With Marfan Syndrome

open access: yesArteriosclerosis, Thrombosis and Vascular Biology, 2015
E. Crosas-Molist   +22 more
semanticscholar   +1 more source

Dopamine D1 Receptor Contributes to Glucocorticoid‐Associated Osteonecrosis of Femoral Head Protection Through the ATF3/CHOP Axis to Inhibit Osteoblastic Apoptosis

open access: yesAdvanced Science, EarlyView.
This work identifies a novel mechanism by which dopamine D1 receptor (DRD1) contributes to the pathogenesis of glucocorticoid (GC)‐associated osteonecrosis of the femoral head (ONFH) through the regulation of osteoblastic apoptosis, indicating that DRD1 serves as a critical mediator of the crosstalk between the nervous and skeletal systems.
Kai Zheng   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy